Reference	Year	Publication Category	hiPSC Line (Healthy Control)	Number of Healthy Control hiPSC-CM Lines	Confluency at Start of Differentiation (%)	WNT Activator
Drawnel, F. M. et al. Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells. Cell Rep, 9, (2014).	2014.0	Selected	CDI-MRB	1		
Bedada, F. B. et al. Acquisition of a quantitative, stoichiometrically conserved ratiometric marker of maturation status in stem cell-derived cardiac myocytes. Stem Cell Reports, 3, (2014).	2014.0	Selected	DF 19-9-11, IPLZ3.13, IBO5.57, hc, 13FLVN0C1	5		Activin A, BMP4, bFGF, CHIR-99021
Lian, X. et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proceedings of the National Academy of Sciences, 109, (2012).	2012.0	Selected	IMR90C4	1		Activin A, BMP4
Lee, D.S. et al. Defined microRNAs induce aspects of maturation in mouse and human embryonic-stem-cell-derived cardiomyocytes. Cell Rep, 12, (2015).	2015.0	Selected				CHIR99021
Dai, D.F. et al. Mitochondrial maturation in human pluripotent stem cell derived cardiomyocytes. Stem Cells International, (2017).	2017.0	Selected	IMR90	1		Activin A, BMP4
Lopez, C.A. et al. Physiological and pharmacological stimulation for in vitro maturation of substrate metabolism in human induced pluripotent stem cell-derived cardiomyocytes. Scientific Reports, 11, (2021).	2021.0	Selected	OX1-19	1		Activin A, CHIR-99021
Sarikhani, M. et al. Sustained activation of AMPK enhances differentiation of human iPSC-derived cardiomyocytes via sirtuin activation. Stem Cell Reports, 15, (2020).	2020.0	Selected	BJ RiPS-A, UCSD142i-86-1	2	80	CHIR99021